Double strategy of blood donation and early screening offers hope for families

▤ Summary

This article explains how blood donation and early carrier screening can reduce the long-term burden of thalassemia. It highlights the role of genetic testing in identifying carriers earlier and helping families make informed reproductive decisions. The piece also points to national prevention programs in countries such as Saudi Arabia, Iran, and Thailand as evidence that screening can reduce affected births and lower costs. BGI Genomics appears in the context of supporting high-throughput sequencing workflows and expanding access to molecular testing. The main message is that prevention plus transfusion support offers a more sustainable path for managing thalassemia.

▦ Linked Companies

Genomics (BGI Group)

$500M to $1B